Blood thinner levels measured in chinese stroke patients
NCT ID NCT04611893
First seen Feb 28, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This study measured the amount of blood thinner (NOAC) in the blood of 308 Chinese patients with atrial fibrillation who had been taking the medication for at least 3 months. The goal was to establish normal reference ranges for these drugs in this specific population. The study did not test a new treatment but aimed to improve monitoring and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chinese University of Hong Kong
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.